Asklepios BioPharmaceutical names new chief executive officer

Edgewise Therapeutics Names Fox to its Board of Directors

Boehringer Ingelheim and Eli Lilly announce FDA acceptance of Jardiance supplemental New Drug Application

First Patient Dosed in Phase 1 Study for BAT8010, an Antibody Drug Conjugate Targeting HER2 for the Treatment of Advanced Solid Tumors

Maze Therapeutics Touts Positive Phase 1 Results from First-in-Human Trial Evaluating MZE001 as a Potential Oral Treatment for Pompe Disease

Dr. Reddy's Laboratories SA to acquire US generic prescription product portfolio from Mayne Pharma

CRO Worldwide Clinical Trials Opens New Lab at Bioanalytical Center of Excellence

Syntach's Cardiac Support system to make oral presentation in Best Innovation Competition at CRT 2023

Sarepta Therapeutics Launches Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4

Geisse Named Chief Executive Officer Curi Bio

Wellesley College President Named to Johnson & Johnson Board of Directors

Revelation Biosciences Raises USD 15.6m Public Offering

Arrow Named Chief Financial Officer at Strateos

Arrow Named Chief Financial Officer at Strateos

Adrestia Therapeutics Co-Founds Ataxia Telangiectasia Research Consortium